Deutsche Bank’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2M | Buy |
341,998
+107,868
| +46% | +$5.76M | 0.01% | 853 |
|
|
2025
Q1 | $9.48M | Sell |
234,130
-39,681
| -14% | -$1.61M | ﹤0.01% | 1020 |
|
|
2024
Q4 | $7.62M | Sell |
273,811
-61,807
| -18% | -$1.72M | ﹤0.01% | 1130 |
|
|
2024
Q3 | $9.63M | Buy |
335,618
+9,571
| +3% | +$275K | ﹤0.01% | 1018 |
|
|
2024
Q2 | $7.65M | Sell |
326,047
-708
| -0.2% | -$16.6K | ﹤0.01% | 1075 |
|
|
2024
Q1 | $8.25M | Buy |
326,755
+136,544
| +72% | +$3.45M | ﹤0.01% | 1080 |
|
|
2023
Q4 | $4.44M | Buy |
190,211
+79,612
| +72% | +$1.86M | ﹤0.01% | 1295 |
|
|
2023
Q3 | $5.59M | Sell |
110,599
-63,951
| -37% | -$3.23M | ﹤0.01% | 1000 |
|
|
2023
Q2 | $8.15M | Sell |
174,550
-345,025
| -66% | -$16.1M | ﹤0.01% | 1057 |
|
|
2023
Q1 | $19.9M | Buy |
519,575
+91,892
| +21% | +$3.52M | 0.01% | 761 |
|
|
2022
Q4 | $23.4M | Buy |
427,683
+414,957
| +3,261% | +$22.7M | 0.01% | 720 |
|
|
2022
Q3 | $433K | Sell |
12,726
-2,037
| -14% | -$69.3K | ﹤0.01% | 2442 |
|
|
2022
Q2 | $139K | Sell |
14,763
-1,768
| -11% | -$16.6K | ﹤0.01% | 3331 |
|
|
2022
Q1 | $234K | Sell |
16,531
-1,640
| -9% | -$23.2K | ﹤0.01% | 3157 |
|
|
2021
Q4 | $384K | Sell |
18,171
-18,796
| -51% | -$397K | ﹤0.01% | 2975 |
|
|
2021
Q3 | $826K | Sell |
36,967
-1,078
| -3% | -$24.1K | ﹤0.01% | 2724 |
|
|
2021
Q2 | $944K | Buy |
38,045
+7,916
| +26% | +$196K | ﹤0.01% | 2788 |
|
|
2021
Q1 | $874K | Sell |
30,129
-35,926
| -54% | -$1.04M | ﹤0.01% | 2737 |
|
|
2020
Q4 | $1.7M | Sell |
66,055
-53,936
| -45% | -$1.39M | ﹤0.01% | 2032 |
|
|
2020
Q3 | $3.7M | Buy |
119,991
+63,277
| +112% | +$1.95M | ﹤0.01% | 1394 |
|
|
2020
Q2 | $1.41M | Buy |
56,714
+54,009
| +1,997% | +$1.35M | ﹤0.01% | 1998 |
|
|
2020
Q1 | $57K | Buy |
2,705
+1,014
| +60% | +$21.4K | ﹤0.01% | 3414 |
|
|
2019
Q4 | $37K | Buy |
1,691
+374
| +28% | +$8.18K | ﹤0.01% | 3955 |
|
|
2019
Q3 | $29K | Buy |
+1,317
| New | +$29K | ﹤0.01% | 4026 |
|